ANN ARBOR STAGE I B-CELL NON-HODGKIN LYMPHOMA

Clinical trials for ANN ARBOR STAGE I B-CELL NON-HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ANN ARBOR STAGE I B-CELL NON-HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for ANN ARBOR STAGE I B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gentler radiation zaps eye lymphoma with fewer side effects

Disease control Ongoing

This study is testing whether a very low dose of radiation aimed at the eye socket can effectively control slow-growing B-cell lymphomas that involve the eye area. It aims to see if this lower dose can work as well as standard treatments while causing fewer side effects. The tria…

Matched conditions: ANN ARBOR STAGE I B-CELL NON-HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 11, 2026 14:53 UTC

ANN ARBOR STAGE I B-CELL NON-HODGKIN LYMPHOMA

Get alerted when new ANN ARBOR STAGE I B-CELL NON-HODGKIN LYMPHOMA trials appear

Gentler radiation zaps eye lymphoma with fewer side effects